Serveur d'exploration Covid

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Generation and characterization of the human neutralizing antibody fragment Fab091 against rabies virus

Identifieur interne : 000C51 ( Main/Exploration ); précédent : 000C50; suivant : 000C52

Generation and characterization of the human neutralizing antibody fragment Fab091 against rabies virus

Auteurs : Chen Li [République populaire de Chine] ; Feng Zhang [République populaire de Chine] ; Hong Lin [République populaire de Chine] ; Zhong-Can Wang [République populaire de Chine] ; Xin-Jian Liu [République populaire de Chine] ; Zhen-Qing Feng [République populaire de Chine] ; Jin Zhu [République populaire de Chine] ; Xiao-Hong Guan [République populaire de Chine]

Source :

RBID : PMC:4002766

Abstract

Aim:

To transform the human anti-rabies virus glycoprotein (anti-RABVG) single-chain variable fragment (scFv) into a Fab fragment and to analyze its immunological activity.

Methods:

The Fab gene was amplified using overlap PCR and inserted into the vector pComb3XSS. The recombinant vector was then transformed into E coli Top10F' for expression and purification. The purified Fab was characterized using SDS-PAGE, Western blotting, indirect ELISA, competitive ELISA, and the fluorescent antibody virus neutralization test (FAVN), respectively, and examined in a Kunming mouse challenge model in vivo.

Results:

A recombinant vector was constructed. The Fab was expressed in soluble form in E coli Top10F'. Specific binding of the Fab to rabies virus was confirmed by indirect ELISA and immunoprecipitation (IP). The neutralizing antibody titer of Fab was 10.26 IU/mL. The mouse group treated with both vaccine and human rabies immunoglobulin (HRIG)/Fab091 (32 IU/kg) showed protection against rabies, compared with the control group (P<0.05, Logrank test).

Conclusion:

The antibody fragment Fab was shown to be a neutralizing antibody against RABVG. It can be used together with other monoclonal antibodies for post-exposure prophylaxis of rabies virus in future studies.


Url:
DOI: 10.1038/aps.2010.209
PubMed: 21278782
PubMed Central: 4002766


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Generation and characterization of the human neutralizing antibody fragment Fab091 against rabies virus</title>
<author>
<name sortKey="Li, Chen" sort="Li, Chen" uniqKey="Li C" first="Chen" last="Li">Chen Li</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">
<institution>Key Laboratory of Antibody Technique of Ministry of Health, Nanjing Medical University</institution>
, Nanjing 210029,
<country>China</country>
</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="aff3">
<institution>Department of Pathology, Nanjing Medical University</institution>
, Nanjing 210029,
<country>China</country>
</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="aff4">
<institution>Department of Pathology, the Affiliated Hospital of Xuzhou Medical College</institution>
, Xuzhou 221002,
<country>China</country>
</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Zhang, Feng" sort="Zhang, Feng" uniqKey="Zhang F" first="Feng" last="Zhang">Feng Zhang</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">
<institution>Key Laboratory of Antibody Technique of Ministry of Health, Nanjing Medical University</institution>
, Nanjing 210029,
<country>China</country>
</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="aff3">
<institution>Department of Pathology, Nanjing Medical University</institution>
, Nanjing 210029,
<country>China</country>
</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Lin, Hong" sort="Lin, Hong" uniqKey="Lin H" first="Hong" last="Lin">Hong Lin</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">
<institution>Key Laboratory of Antibody Technique of Ministry of Health, Nanjing Medical University</institution>
, Nanjing 210029,
<country>China</country>
</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Wang, Zhong Can" sort="Wang, Zhong Can" uniqKey="Wang Z" first="Zhong-Can" last="Wang">Zhong-Can Wang</name>
<affiliation wicri:level="1">
<nlm:aff id="aff2">
<institution>Huadong Medical Institute of Biotechniques</institution>
, Nanjing 210002,
<country>China</country>
</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Liu, Xin Jian" sort="Liu, Xin Jian" uniqKey="Liu X" first="Xin-Jian" last="Liu">Xin-Jian Liu</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">
<institution>Key Laboratory of Antibody Technique of Ministry of Health, Nanjing Medical University</institution>
, Nanjing 210029,
<country>China</country>
</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Feng, Zhen Qing" sort="Feng, Zhen Qing" uniqKey="Feng Z" first="Zhen-Qing" last="Feng">Zhen-Qing Feng</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">
<institution>Key Laboratory of Antibody Technique of Ministry of Health, Nanjing Medical University</institution>
, Nanjing 210029,
<country>China</country>
</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="aff3">
<institution>Department of Pathology, Nanjing Medical University</institution>
, Nanjing 210029,
<country>China</country>
</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Zhu, Jin" sort="Zhu, Jin" uniqKey="Zhu J" first="Jin" last="Zhu">Jin Zhu</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">
<institution>Key Laboratory of Antibody Technique of Ministry of Health, Nanjing Medical University</institution>
, Nanjing 210029,
<country>China</country>
</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="aff2">
<institution>Huadong Medical Institute of Biotechniques</institution>
, Nanjing 210002,
<country>China</country>
</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Guan, Xiao Hong" sort="Guan, Xiao Hong" uniqKey="Guan X" first="Xiao-Hong" last="Guan">Xiao-Hong Guan</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">
<institution>Key Laboratory of Antibody Technique of Ministry of Health, Nanjing Medical University</institution>
, Nanjing 210029,
<country>China</country>
</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">21278782</idno>
<idno type="pmc">4002766</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4002766</idno>
<idno type="RBID">PMC:4002766</idno>
<idno type="doi">10.1038/aps.2010.209</idno>
<date when="2011">2011</date>
<idno type="wicri:Area/Pmc/Corpus">000004</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000004</idno>
<idno type="wicri:Area/Pmc/Curation">000004</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000004</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000559</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000559</idno>
<idno type="wicri:Area/Ncbi/Merge">000206</idno>
<idno type="wicri:Area/Ncbi/Curation">000206</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000206</idno>
<idno type="wicri:doubleKey">1671-4083:2011:Li C:generation:and:characterization</idno>
<idno type="wicri:Area/Main/Merge">000C53</idno>
<idno type="wicri:Area/Main/Curation">000C51</idno>
<idno type="wicri:Area/Main/Exploration">000C51</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Generation and characterization of the human neutralizing antibody fragment Fab091 against rabies virus</title>
<author>
<name sortKey="Li, Chen" sort="Li, Chen" uniqKey="Li C" first="Chen" last="Li">Chen Li</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">
<institution>Key Laboratory of Antibody Technique of Ministry of Health, Nanjing Medical University</institution>
, Nanjing 210029,
<country>China</country>
</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="aff3">
<institution>Department of Pathology, Nanjing Medical University</institution>
, Nanjing 210029,
<country>China</country>
</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="aff4">
<institution>Department of Pathology, the Affiliated Hospital of Xuzhou Medical College</institution>
, Xuzhou 221002,
<country>China</country>
</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Zhang, Feng" sort="Zhang, Feng" uniqKey="Zhang F" first="Feng" last="Zhang">Feng Zhang</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">
<institution>Key Laboratory of Antibody Technique of Ministry of Health, Nanjing Medical University</institution>
, Nanjing 210029,
<country>China</country>
</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="aff3">
<institution>Department of Pathology, Nanjing Medical University</institution>
, Nanjing 210029,
<country>China</country>
</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Lin, Hong" sort="Lin, Hong" uniqKey="Lin H" first="Hong" last="Lin">Hong Lin</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">
<institution>Key Laboratory of Antibody Technique of Ministry of Health, Nanjing Medical University</institution>
, Nanjing 210029,
<country>China</country>
</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Wang, Zhong Can" sort="Wang, Zhong Can" uniqKey="Wang Z" first="Zhong-Can" last="Wang">Zhong-Can Wang</name>
<affiliation wicri:level="1">
<nlm:aff id="aff2">
<institution>Huadong Medical Institute of Biotechniques</institution>
, Nanjing 210002,
<country>China</country>
</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Liu, Xin Jian" sort="Liu, Xin Jian" uniqKey="Liu X" first="Xin-Jian" last="Liu">Xin-Jian Liu</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">
<institution>Key Laboratory of Antibody Technique of Ministry of Health, Nanjing Medical University</institution>
, Nanjing 210029,
<country>China</country>
</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Feng, Zhen Qing" sort="Feng, Zhen Qing" uniqKey="Feng Z" first="Zhen-Qing" last="Feng">Zhen-Qing Feng</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">
<institution>Key Laboratory of Antibody Technique of Ministry of Health, Nanjing Medical University</institution>
, Nanjing 210029,
<country>China</country>
</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="aff3">
<institution>Department of Pathology, Nanjing Medical University</institution>
, Nanjing 210029,
<country>China</country>
</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Zhu, Jin" sort="Zhu, Jin" uniqKey="Zhu J" first="Jin" last="Zhu">Jin Zhu</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">
<institution>Key Laboratory of Antibody Technique of Ministry of Health, Nanjing Medical University</institution>
, Nanjing 210029,
<country>China</country>
</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<nlm:aff id="aff2">
<institution>Huadong Medical Institute of Biotechniques</institution>
, Nanjing 210002,
<country>China</country>
</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Guan, Xiao Hong" sort="Guan, Xiao Hong" uniqKey="Guan X" first="Xiao-Hong" last="Guan">Xiao-Hong Guan</name>
<affiliation wicri:level="1">
<nlm:aff id="aff1">
<institution>Key Laboratory of Antibody Technique of Ministry of Health, Nanjing Medical University</institution>
, Nanjing 210029,
<country>China</country>
</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Acta Pharmacologica Sinica</title>
<idno type="ISSN">1671-4083</idno>
<idno type="eISSN">1745-7254</idno>
<imprint>
<date when="2011">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<sec>
<title>Aim:</title>
<p>To transform the human anti-rabies virus glycoprotein (anti-RABVG) single-chain variable fragment (scFv) into a Fab fragment and to analyze its immunological activity.</p>
</sec>
<sec>
<title>Methods:</title>
<p>The Fab gene was amplified using overlap PCR and inserted into the vector pComb3XSS. The recombinant vector was then transformed into
<italic>E coli</italic>
Top10F' for expression and purification. The purified Fab was characterized using SDS-PAGE, Western blotting, indirect ELISA, competitive ELISA, and the fluorescent antibody virus neutralization test (FAVN), respectively, and examined in a Kunming mouse challenge model
<italic>in vivo</italic>
.</p>
</sec>
<sec>
<title>Results:</title>
<p>A recombinant vector was constructed. The Fab was expressed in soluble form in
<italic>E coli</italic>
Top10F'. Specific binding of the Fab to rabies virus was confirmed by indirect ELISA and immunoprecipitation (IP). The neutralizing antibody titer of Fab was 10.26 IU/mL. The mouse group treated with both vaccine and human rabies immunoglobulin (HRIG)/Fab091 (32 IU/kg) showed protection against rabies, compared with the control group (
<italic>P</italic>
<0.05, Logrank test).</p>
</sec>
<sec>
<title>Conclusion:</title>
<p>The antibody fragment Fab was shown to be a neutralizing antibody against RABVG. It can be used together with other monoclonal antibodies for post-exposure prophylaxis of rabies virus in future studies.</p>
</sec>
</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>République populaire de Chine</li>
</country>
</list>
<tree>
<country name="République populaire de Chine">
<noRegion>
<name sortKey="Li, Chen" sort="Li, Chen" uniqKey="Li C" first="Chen" last="Li">Chen Li</name>
</noRegion>
<name sortKey="Feng, Zhen Qing" sort="Feng, Zhen Qing" uniqKey="Feng Z" first="Zhen-Qing" last="Feng">Zhen-Qing Feng</name>
<name sortKey="Feng, Zhen Qing" sort="Feng, Zhen Qing" uniqKey="Feng Z" first="Zhen-Qing" last="Feng">Zhen-Qing Feng</name>
<name sortKey="Guan, Xiao Hong" sort="Guan, Xiao Hong" uniqKey="Guan X" first="Xiao-Hong" last="Guan">Xiao-Hong Guan</name>
<name sortKey="Li, Chen" sort="Li, Chen" uniqKey="Li C" first="Chen" last="Li">Chen Li</name>
<name sortKey="Li, Chen" sort="Li, Chen" uniqKey="Li C" first="Chen" last="Li">Chen Li</name>
<name sortKey="Lin, Hong" sort="Lin, Hong" uniqKey="Lin H" first="Hong" last="Lin">Hong Lin</name>
<name sortKey="Liu, Xin Jian" sort="Liu, Xin Jian" uniqKey="Liu X" first="Xin-Jian" last="Liu">Xin-Jian Liu</name>
<name sortKey="Wang, Zhong Can" sort="Wang, Zhong Can" uniqKey="Wang Z" first="Zhong-Can" last="Wang">Zhong-Can Wang</name>
<name sortKey="Zhang, Feng" sort="Zhang, Feng" uniqKey="Zhang F" first="Feng" last="Zhang">Feng Zhang</name>
<name sortKey="Zhang, Feng" sort="Zhang, Feng" uniqKey="Zhang F" first="Feng" last="Zhang">Feng Zhang</name>
<name sortKey="Zhu, Jin" sort="Zhu, Jin" uniqKey="Zhu J" first="Jin" last="Zhu">Jin Zhu</name>
<name sortKey="Zhu, Jin" sort="Zhu, Jin" uniqKey="Zhu J" first="Jin" last="Zhu">Jin Zhu</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C51 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000C51 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     PMC:4002766
   |texte=   Generation and characterization of the human neutralizing antibody fragment Fab091 against rabies virus
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:21278782" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Fri Mar 27 18:14:15 2020. Site generation: Sun Jan 31 15:15:08 2021